Send to:

Choose Destination
See comment in PubMed Commons below
Curr Cardiol Rep. 2014 Jul;16(7):501. doi: 10.1007/s11886-014-0501-8.

Heart failure with preserved ejection fraction: current understandings and challenges.

Author information

  • 1The Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.


Heart failure (HF) is the leading cause of hospitalization among older adults and the prevalence is growing with the aging populations in western countries. Approximately one-half of patients with HF have preserved ejection fraction (HFpEF). In contrast to HF with reduced EF (HFrEF), there is no proven effective treatment for HFpEF. The pathophysiology of HFpEF is complex, and the dominant mechanisms leading to symptoms of HF often vary between afflicted patients, confounding efforts to apply "one-size fits all" types of therapeutic approaches. Current treatment strategies focus on control of volume status and comorbidities, but future research aimed at individualized therapies holds promise to improve outcomes in this increasingly prevalent form of cardiac failure.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk